News About: Pharm. Industry
A 10 trillion won of pharmaceutical production.
The pharmaceutical production value has surpassed to the level of 10 trillion won, showing also a shift from a depression to a recovering trend.
The KPMA statistics of "2004 pharmaceutical production" indicat...
Drug wholesalers rage against Zuellig on Cialis margin policy.
Zuellig notified a margin rate reduction of Cialis, an impotence drug, to drug wholesalers by 2% point down effective from July 1, provoking wholesaler's anger. Zuellig is representing the wholesale distribution to Li...
Bukwan agreed to transfer technology of Clebutine.
Bukwang made a technical transfer agreement with American Pharmasset Inc. for Clebutine, a drug for B viral hepatitis, on June 24.
The agreement granted Pharmasset to distribute Clebutine in other countries except ...
Patent attorney to caution local company on memorandum in patent disputes.
The New Drug Research Association took the 2nd of 11th annual pharmaceutical intermediate and raw material drug development meeting at Lakehill Golftel on June 24, in which a patent attorney Roh Chae-cheol, the repres...
Cho-A to export Green Tea ampules to America.
Cho-A pharmaceutical company announced that "Da Hyang Green Tea Concentrate" which was mainly sold for the domestic markets would be exported to the United States under the name of "Bosung Green Tea Concentrate".
T...
Clinical results of Il Yang's Ilaprazole showing excellent.
Il Yang announced that a new anti-peptic ulcer drug, Ilaprazole revealed the most significant profile in the clinical studies out of the existing PPI anti-peptic ulcer drugs.
According to a clinical study report of...
KFDA approved Lyrica for neuropathic pain.
Pfizer Korea said that the KFDA approved Lyrica (pregabalin) for neuropathic pain associated with diabetic peripheral neuropathy and adjunctive therapy in the treatment of partial seizures in adults on June 14.
Lyr...
KPWA to oppose Daewoong's new wholesale policy.
The Korea Pharmaceutical Wholesalers Association (KPWA) determined to oppose against the Daewoong's new wholesale policy and to await for Green Croos's further transaction.
The KPWA has confronted with Daewoong's n...
Schering Korea to launch injectable testosterone for male climacterics.Schering Korea has launched Nebido, an injectable testosterone hormone for the male climacteric syndrome, administering once every 3 month to keep a normal blood level of testos...
|
Celltrion to contract biological product supply with BMS
Bristol-Myer Squibb (BMS), an American gigantic pharmaceutical company, and Celltrion, a Korea bio venture company, signed an agreement on June 22 covering the production and supply of biological products to BMS for 1...
